The role of iNOS and PHOX in periapical bone resorption

Journal of Dental Research

Volumn 90, Issue 4, 2011, Pages 495-500

  Silva, M J B ^a   Sousa, L M A ^a   Lara, V P L ^a   Cardoso, F P ^a   Junior G M ^b   Totola, A H ^c   Caliari, M V ^a   Romero, O B ^a   Silva, G A B ^a   Ribeiro Sobrinho, A P ^a   Vieira, L Q ^a,d  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSIDADE DE ITAÚNA   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO JOÃO DEL REI   (Brazil)

^d FEDERAL UNIVERSITY OF OURO PRETO   (Brazil)

Author keywords

iNOS; periapical lesion; ROS

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; AUTACOID; BIOLOGICAL MARKER; CCL2 PROTEIN, MOUSE; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; ISOENZYME; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NOS2 PROTEIN, MOUSE; OSTEOCLAST DIFFERENTIATION FACTOR; REACTIVE OXYGEN METABOLITE; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TARTRATE-RESISTANT ACID PHOSPHATASE; TNFRSF11A PROTEIN, MOUSE; TNFSF11 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ALVEOLAR BONE LOSS; ANIMAL; C57BL MOUSE; COMPARATIVE STUDY; CONFERENCE PAPER; DISEASE COURSE; DISEASE MODEL; ENZYMOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; MOUSE STRAIN; PATHOLOGY; PERIODONTAL LIGAMENT; PHAGOCYTE; PHYSIOLOGY; TOOTH PERIAPICAL DISEASE;

ACID PHOSPHATASE; ALVEOLAR BONE LOSS; ANIMALS; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; ISOENZYMES; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; NADPH OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PERIAPICAL PERIODONTITIS; PERIODONTAL LIGAMENT; PHAGOCYTES; RANK LIGAND; REACTIVE OXYGEN SPECIES; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79954577479     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510391792     Document Type: Conference Paper

References (40)

1. Armour KJ, Armour KE, van't Hof RJ, Reid DM, Wei XQ, Liew FY, et al. (2001). Activation of the inducible nitric oxide synthase pathway contributes to inflammation-induced osteoporosis by suppressing bone formation and causing osteoblast apoptosis. Arthritis Rheum 44: 2790-2796. (Pubitemid 34016198)
2. Babior BM (2004). NADPH oxidase. Curr Opin Immunol 16: 42-47. (Pubitemid 38198116)
3. Brito C., Naviliat M., Tiscornia AC, Vuillier F., Gualco G., Dighiero G., et al. (1999). Peroxynitrite inhibits T lymphocyte activation and proliferation by promoting impairment of tyrosine phosphorylation and peroxynitrite-driven apoptotic death. J Immunol 162: 3356-3366. (Pubitemid 29313585)
4. Cuzzocrea S., Mazzon E., Dugo L., Genovese T., Di Paola R., Ruggeri Z., et al. (2003). Inducible nitric oxide synthase mediates bone loss in ovariectomized mice. Endocrinology 144: 1098-1107. (Pubitemid 36262876)
5. Desai A., Miller MJ, Huang X., Warren JS (2003). Nitric oxide modulates MCP-1 expression in endothelial cells: implications for the pathogenesis of pulmonary granulomatous vasculitis. Inflammation 27: 213-223. (Pubitemid 37034469)
6. Fan X., Roy E., Zhu L., Murphy TC, Ackert-Bicknell C., Hart CM, et al. (2004). Nitric oxide regulates receptor activator of nuclear factorkappaB ligand and osteoprotegerin expression in bone marrow stromal cells. Endocrinology 145: 751-759. (Pubitemid 38183818)
7. Fan X., Rahnert JA, Murphy TC, Nanes MS, Greenfield EM, Rubin J. (2006). Response to mechanical strain in an immortalized pre-osteoblast cell is dependent on ERK1/2. J. Cell Physiol 207: 454-460.
8. Fierro IM, Nascimento-DaSilva V., Arruda MA, Freitas MS, Plotkowski MC, Cunha FQ, et al. (1999). Induction of NOS in rat blood PMN in vivo and in vitro: modulation by tyrosine kinase and involvement in bactericidal activity. J Leukoc Biol 65: 508-514. (Pubitemid 29160179)
9. Gao Y., Grassi F., Ryan MR, Terauchi M., Page K., Yang X., et al. (2007). IFNgamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation. J Clin Invest 117: 122-132. (Pubitemid 46048459)
10. Gyurko R., Boustany G., Huang PL, Kantarci A., Van Dyke TE, Genco CA, et al. (2003). Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis. Infect Immun 71: 4917-4924. (Pubitemid 37070733)
11. Hama S., Takeichi O., Saito I., Ito K. (2007). Involvement of inducible nitric oxide synthase and receptor for advanced glycation end products in periapical granulomas. J Endod 33: 137-141.
12. Hofbauer LC, Heufelder AE (2001). The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis. Arthritis Rheum 44: 253-259. (Pubitemid 32207017)
13. Holliday LS, Dean AD, Lin RH, Greenwald JE, Gluck SL (1997). Low NO concentrations inhibit osteoclast formation in mouse marrow cultures by cGMP-dependent mechanism. Am J Physiol 272 (3Pt2). F283 - F291.
14. Huang FP, Niedbala W., Wei XQ, Xu D., Feng GJ, Robinson JH, et al. (1998). Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol 28: 4062-4070. (Pubitemid 28558636)
15. Kasten TP, Collin-Osdoby P., Patel N., Osdoby P., Krukowski M., Misko TP, et al. (1994). Potentiation of osteoclast bone-resorption activity by inhibition of nitric oxide synthase. Proc Natl Acad Sci USA 91: 3569-3573. (Pubitemid 24139471)
16. Kawashima N., Suzuki N., Yang G., Ohi C., Okuhara S., Nakano-Kawanishi H., et al. (2007). Kinetics of RANKL, RANK and OPG expressions in experimentally induced rat periapical lesions. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103: 707-711.
17. Koh J-M., Lee Y-S., Kim YS, Kim DJ, Kim H-H., Park J-Y., et al. (2006). Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 21: 1003-1011. (Pubitemid 43962829)
18. Kong YY, Yoshida H., Sarosi I., Tan HL, Timms E., Capparelli C., et al. (1999). OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397: 315-323.
19. Lander HM (1997). An essential role for free radicals and derived species in signal transduction. FASEB J 11: 118-124. (Pubitemid 27097584)
20. Lappin DF, Kjeldsen M., Sander L., Kinane DF (2000). Inducible nitric oxide synthase expression in periodontitis. J Periodontal Res 35: 369-373.
21. Lee NK, Choi YG, Baik JY, Han SY, Jeong DW, Bae YS, et al. (2005). A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation. Blood 106: 852-859. (Pubitemid 41076424)
22. Lee SK, Huang H., Lee SW, Kim KH, Kim KK, Kim H-M., et al. (2004). Involvement of iNOS-dependent NO production in the stimulation of osteoclast survival by TNF-alpha. Exp Cell Res 298: 359-368. (Pubitemid 38950854)
23. Leonard N., Bishop AE, Polak JM, Talbot IC (1998). Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment. J Clin Pathol 51: 750-753. (Pubitemid 28480331)
24. Li X., Qin L., Bergenstock M., Bevelock LM, Novack DV, Partridge NC (2007). Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts. J Biol Chem 282: 33098-33106. (Pubitemid 350159306)
25. Lin S-K., Kok S-H., Lin L-D., Wang C-C., Kuo MY, Lin C-T., et al. (2007). Nitric oxide promotes the progression of periapical lesion via inducing macrophage and osteoblast apoptosis. Oral Microbiol Immunol 22: 24-29. (Pubitemid 46096193)
26. Radi R., Peluffo G., Alvarez MN, Naviliat M., Cayota A. (2001). Unraveling peroxynitrite formation in biological systems. Free Radic Biol Med 30: 463-488. (Pubitemid 32162954)
27. Rahnert J., Fan X., Case N., Murphy TC, Grassi F., Sen B., et al. (2008). The role of nitric oxide in the mechanical repression of RANKL in bone stromal cells. Bone 43: 48-54.
28. Ralston SH, Grabowski PS (1996). Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins. Bone 19: 29-33. (Pubitemid 26318741)
29. Rhee SG (1999). Redox signaling: hydrogen peroxide as intracellular messenger. Exp Mol Med 31: 53-59. (Pubitemid 29326708)
30. Rubin J., Rubin C., Jacobs CR (2006). Molecular pathways mediating mechanical signaling in bone. Gene 367: 1-16. (Pubitemid 43286736)
31. Sasaki H., Yamamoto H., Tominaga K., Masuda K., Kawai T., Teshima-Kondo S., et al. (2009 a). Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues. Free Radic Biol Med 47: 189-199.
32. Sasaki H., Yamamoto H., Tominaga K., Masuda K., Kawai T., Teshima-Kondo S., et al. (2009 b). NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts. J Med Invest 56: 33-41.
33. Schletter J., Heine H., Ulmer AJ, Rietschel ET (1995). Molecular mechanisms of endotoxin activity. Arch Microbiol 164: 383-389. (Pubitemid 26018509)
34. Schmittgen TD, Livak KJ (2008). Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108. (Pubitemid 351818697)
35. Silva MJ, Vieira LQ, Sobrinho AP (2008). The effects of mineral trioxide aggregates on cytokine production by mouse pulp tissue. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 105: e70 - e76.
36. Takeichi O., Saito I., Okamoto Y., Tsurumachi T., Saito T. (1998). Cytokine regulation on the synthesis of nitric oxide in vivo by chronically infected human polymorphonuclear leucocytes. Immunology 93: 275-280. (Pubitemid 28088297)
37. Vernal R., Dezerega A., Dutzan N., Chaparro A., León R., Chandía S., et al. (2006). RANKL in human periapical granuloma: possible involvement in periapical bone destruction. Oral Dis 12: 283-289. (Pubitemid 43736416)
38. Xie QW, Cho HJ, Calaycay J., Mumford RA, Swiderek KM, Lee TD, et al. (1992). Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256: 225-228.
39. Yang S., Ries WL, Key LL (1998). Nicotinamide adenine dinucleotide phosphate oxidase in the formation of superoxide in osteoclasts. Calcif Tissue Int 63: 346-350. (Pubitemid 28443420)
40. Zheng H., Yu X., Collin-Osdoby P., Osdoby P. (2006). RANKL stimulates inducible nitric-oxide synthase expression and nitric oxide production in developing osteoclasts. An autocrine negative feedback mechanism triggered by RANKL-induced interferon-beta via NF-kappaB that restrains osteoclastogenesis and bone resorption. J Biol Chem 281: 15809-15820. (Pubitemid 43848471)